GovWire

Cochlear / Oticon merger inquiry

Competition Markets Authority

June 22
12:08 2023

Phase 2

Administrative timetable

Referral date: 20 December 2022

Statutory deadline: 31 July 2023

Contact

Cochlear.Oticon@cma.gov.uk

Final report

22 June 2023: The CMA has published its final report.

Notice of extension of statutory period

Responses to provisional findings and possible remedies

Provisional findings

20 April 2023: The CMA has provisionally found competition concerns as part of its in-depth investigation of the anticipated acquisition by Cochlear Limited of the hearing implants business of Demant A/S, known as Oticon Medical.

The deadline for submitting responses to the provisional findings is Thursday 11 May 2023.

The deadline for submitting responses to the notice of possible remedies is Thursday 4 May 2023.

Responses to the issues statement

Issues statement

20 January 2023: The issues statement sets out the scope of the inquiry. It outlines initial theories on what might be adversely affecting competition, but it does not set out findings or conclusions. The deadline for submissions on the issues statement is 5pm, 3 February 2023.

Inquiry group appointed

21 December 2022: The CMA has appointed the inquiry group.

Kip Meek (Chair), Anne Fletcher, Keith Richards and David Thomas.

Terms of reference

20 December 2022: The CMA has referred the anticipated acquisition by Cochlear Limited of the hearing implants business of Demant A/S, known as Oticon Medical, for an in-depth investigation.

Statutory timetable

Phase 1 Action
6 December 2022 Phase 1 decision announced
14 November 2022 Initial enforcement order
11 October 2022 to 25 October 2022 Invitation to comment
11 October 2022 Launch of merger inquiry

Phase 1

Reference decision

20 December 2022: The CMA has referred the anticipated acquisition by Cochlear Limited of the hearing implants business of Demant A/S, known as Oticon Medical, for an in-depth investigation, on the basis that, on the information currently available to it, it is or may be the case that this merger may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom.

Reference unless undertakings accepted

6 December 2022: The CMA has decided, on the information currently available to it, that it is or may be the case that this merger may be expected to result in a substantial lessening of competition within a market or markets in the Un

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: